Individuals managing chronic gut issues like IBS, IBD, or leaky gut Those seeking ongoing wellness maintenance rather than immediate results Anyone looking for general inflammation control and systemic support Individuals who prefer a slow-release option to support daily function and recovery By targeting the intestines more directly, Delayed BPC-157 is particularly helpful for those with digestive sensitivity or those using the peptide for internal inflammation rather than muscular or skeletal pain
To put that in perspective, it's nearly double the weight loss seen with semaglutide (Wegovy) in similar trials
Individual results vary, and the best plan is personalized to the patient's health history and goals
The epidemiological rate of 35 per 1,000 person-years (3.5%) includes a broad definition that may encompass milder sensory changes as well as true allodynia
If you're already on a GLP-1 and interested in adding BPC-157, or want to explore both from the start, our medical team can evaluate your history, build a personalized plan, and provide pharmaceutical-grade compounds